Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Choroid plexus enlargement in multiple sclerosis is associated with decreased brain volume
Multiple Sclerosis
P12 - Poster Session 12 (5:30 PM-6:30 PM)
12-008

Increased CPV has been reported in multiple sclerosis (MS) and has been suggested to reflect CP inflammation. The association between CPV and neurodegeneration remains relatively poorly understood. 

To assess the relationship between CPV and tissue-specific volumetric measures in the brain.

179 MS patients and 59 healthy controls (HCs), group matched for age and sex, were imaged on a 3T MRI scanner with an imaging protocol that included a 3D T1-weighted scan and T2-weighted FLAIR. T2 lesion volume (T2-LV) was measured. For each individual, SIENAX was run on a lesion inpainted image to obtain total volumes of brain (BV), grey matter (GMV), white matter (WMV), and ventricular volume (VV). CPV was automatically calculated from the same image using a Gaussian Mixture Models-based approach. CPV was normalized by the SIENAX scaling factor. Group comparisons and correlations were adjusted for age and sex. A univariate general linear model was constructed to predict CPV from VV, while assessing the interaction effect between group and VV.

MS patients presented with significantly larger CP fractions when compared to HCs (2847 ± 967 vs. 2399 ± 876 mL, p=0.010). Age was significantly positively correlated with CP fraction (p ≤ 0.005) in both groups. Significant correlations were observed in MS patients between CP and GMV (r=-0.365), WMV (r=-0.188), BV  (r=-0.365) ,VV (r=0.691), and T2-LV (r=0.293) (all p ≤ 0.012). In the HC group, CP fraction was only associated with VV (r=0.806, p < 0.001). A significant group x VV interaction effect (p < 0.001) was identified when predicting CPV.

Unlike in HCs, CPV in MS patients relates to regional tissue volumes and T2-LV. CP enlargement is not fully explained by increased VV, potentially suggesting a link between CP inflammation and neurodegeneration. 

Authors/Disclosures
Niels Bergsland (Buffalo Neuroimaging Analysis Center / State University of New York At Buffalo)
PRESENTER
Prof. Bergsland has nothing to disclose.
Michael G. Dwyer III, MD, PhD (Buffalo Neurological Analysis Center) Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Dejan Jakimovski, MD, PhD (Buffalo Neuroimaging Analysis Center, University at Buffalo) Dr. Jakimovski has nothing to disclose.
Bianca Weinstock-Guttman, MD (Department of Neurology, University At Buffalo) Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Robert Zivadinov, MD, PhD, FAAN (Buffalo Neuroimaging Analysis Center) The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.